NVO Intrinsic Value Calculation | Should You Buy Now?
Автор: Null Rise
Загружено: 2026-02-01
Просмотров: 164
Описание:
We're examining Novo Nordisk, a key player in the pharmaceuticals industry, ahead of their earnings report. This stock analysis dives into their financial statements to assess whether NVO stock is a compelling investment opportunity, especially given potential market pullbacks. We aim to confirm if their reported numbers align with our expectations for this biotech investing leader.
NVO is down 60% from its peak. Would the bleeding continue, or would the stock explode and reach new all-time highs?
Novo Nordisk (NVO) is a global pharmaceutical company focused on diabetes, obesity, and metabolic disease treatments, best known for GLP-1 drugs like Ozempic and Wegovy, with industry-leading expertise in insulin and injectable biologics manufacturing. What are your thoughts on this industry? Is there room to grow? Would there be more competition?
🚨 This is not financial advice! Always do your own research before making investment decisions.
🔔 Don't forget to like, comment, and subscribe for more stock analysis!
Want to learn what mistakes to avoid? Watch 👉 • 6 Investing Lessons From Losing 88% | Mist...
0:00 Introduction
1:18 Financials
4:21 Residual Cash
6:54 Future Projections
10:35 Perpetual Growth Rate Valuation
11:12 EBITDA valuation
12:22 Targets
13:13 Final Thought
#novonordisk #nvo #stockmarket #investing #valueinvesting #stockanalysis
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
